- Savara Inc at Guggenheim Healthcare Talks Biotechnology Conference TranscriptFeb 07, 2024
- Savara Inc at Jefferies Healthcare Conference TranscriptJun 09, 2023
- Savara Inc at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (Virtual) TranscriptSep 20, 2021
- Savara Inc Annual Shareholders Meeting TranscriptJun 10, 2021
- Q2 2020 Savara Inc Earnings Call TranscriptAug 06, 2020$2.04 (-3.77%)Earnings
- Savara Inc Annual Shareholders Meeting TranscriptMay 27, 2020
- Q1 2020 Savara Inc Earnings Call TranscriptMay 07, 2020$2.55 (+5.81%)Earnings
- Savara Inc. - Special Call TranscriptApr 03, 2020
- Q4 2019 Savara Inc Earnings Call TranscriptMar 12, 2020$2.55 (+8.05%)Earnings
- Q3 2019 Savara Inc Earnings Call TranscriptNov 07, 2019$0.91 (-1.09%)Earnings
- Q2 2019 Savara Inc Earnings Call TranscriptAug 08, 2019$2.51 (+2.03%)Earnings
- Savara Inc Announces Results of IMPALA, a Phase 3 Study of Molgradex for the Treatment of Autoimmune Alveolar Pulmonary Proteinosis (aPAP) TranscriptJun 12, 2019
- Q1 2019 Savara Inc Earnings Call TranscriptMay 09, 2019$10.72 (-2.46%)Earnings
- Q4 2018 Savara Inc Earnings Call TranscriptMar 13, 2019$8.6 (+1.30%)Earnings
Q1 2020 Savara Inc Earnings Call Transcript
Good day, and welcome to the Savara Conference Call.
(Operator Instructions) An audio webcast of this call will be available on the Investors section of Savara's website at savarapharma.com. This call is subject to copyright and is the property of Savara. All recordings, reproduction and transmission of this call without the express written consent of Savara is strictly prohibited. As a reminder, today's call is being recorded.
I would now like to turn the call over to Anne Erickson, head investor of relations (sic) [Head of Investor Relations] and Corporate Communications at Savara. Please go ahead, ma'am.
Good afternoon and thank you for joining us today.
A press release reporting our first quarter 2020 financial results was issued earlier today, May 7, 2020, and can be found on the Investors section of our website at savarapharma.com. If you've not received this release or you would like to be added to the company's distribution list, please e-mail me at ir
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)